Skip to main content

Animations

MJFF Publications

4061 - 4070 of 8818 Results
Title
Year
  • Year
  • 2019
  • 2017
  • 2016
  • 2016
  • 2025
  • 2017
  • 2018
  • 2025
  • 2011
  • 2016
  • Summary Details
    OPEN
    Title: Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.101856
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: multiplierz v2.0: A Python‐based ecosystem for shared access and analysis of native mass spectrometry data
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201700091
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Post‐traumatic Functional Mirror Movements in Klippel‐Feil Syndrome
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12405
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptide
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01132-7
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives
    Journal Name: Brain Topography
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/241754
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.